BMEZ insider buying and SEC filings, explained
BlackRock Health Sciences Term Trust · CIK 1785971
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- State of incorporation
- MD
- Fiscal year end
- Dec 31
- Former names
- BlackRock Health Sciences Trust II
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$308K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 18–19, 2025 | Sale | Robert W Fairbairn (Director) sold 20,589 shares directly and indirectly (by spouse) between Dec 18, 2025 and Dec 19, 2025 at about $14.98 ($308K). Direct holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 22, 2025 |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BMEZ in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.